Join
Live feed
·
PRReleasevia Quantisnow
Launch One Acquisition Corp. logo

Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome

ByQuantisnow·Wall Street's wire, on your screen.
LPAA· Launch One Acquisition Corp.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LPAA (Launch One Acquisition Corp.) and more on Quantisnow.